University of California San Francisco
Give to UCSF
UCSF scientists will receive two grants totaling $15.1 million over the next five years to expand their research into how genes affect an individual’s response to medication and to strengthen a global network of researchers involved in these efforts.
Larissa Podust, PhD, is working on a new drug for Chagas disease, a neglected scourge.
A diabetes-care program designed by clinical pharmacy faculty in the UCSF School of Pharmacy Center for Self-Care has just launched in Northern California as a service for members of the California Public Employees Retirement System (CalPERS) with Blue Shield health coverage.
The heavy burden of hunger in the United States helps explain why the poor are at higher risk for obesity, high blood pressure and diabetes, according to an editorial in the July 1 <i>New England Journal of Medicine</i> co-authored by two UCSF faculty members.
Antibiotic-resistant Staph infection is not the only emerging bacterial threat. Now a different bug -- Clostridium difficile -- is gaining strength.
James McKerrow, leader of the Sandler Center for Drug Discovery at UCSF, was honored with the 2009 Mendel Medal for his work identifying the vulnerabilities of disease-causing parasites and for devising new strategies to fight them.
UCSF’s Renee Navarro and Amy Levine, both champions of diversity, played pivotal roles in the recent UC Diversity Pipeline Initiative, which encourages female students to pursue careers as faculty in the health sciences.
Leslie Benet, a professor in the schools of pharmacy and medicine, been honored with the premier prize from the American Society for Clinical Pharmacology and Therapeutics and his seventh honorary doctorate.
Insight into pneumonia deaths due to antibiotic-resistant <cite>Staphylococcus aureus</cite> infections emerges from UCSF study.
UCSF Chancellor Sue Desmond-Hellmann recently congratulated members of the UCSF community who have served at the University for a decade or longer.
An international study published in the March 25 <em>New England Journal of Medicine</em> showed what researchers call a clinical breakthrough in one of the greatest unmet needs for patients with advanced liver disease.
The UCSF School of Pharmacy is charting new territory with an interdisciplinary education program for health care professionals on Medicare Part D.